These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3680089)

  • 1. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
    Fu KP; Hetzel N; Gregory FJ; Hung PP
    J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic mice.
    Fu KP; Hetzel N; Hung PP; Gregory FJ
    Chemotherapy; 1986; 32(2):166-72. PubMed ID: 3698725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
    Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
    Infection; 1989; 17(5):311-5. PubMed ID: 2599653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
    Zuravleff JJ; Chervenick P; Yu VL; Muder RR; Diven WF
    J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
    Fu KP; Vince T; McCloud S; Gregory FJ; Chiang ST; Hung PP
    Drugs Exp Clin Res; 1985; 11(11):787-91. PubMed ID: 3939215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
    Johnson DE; Calia FM; Snyder MJ; Warren JW; Schimpff SC
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice.
    Mattie H; Hoogeterp JJ; Terporten P
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S26-9. PubMed ID: 3125518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice.
    Hoogeterp JJ; Mattie H; Terporten P
    Infection; 1988; 16(1):58-62. PubMed ID: 3129373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
    Opal SM; Cross AS; Kelly NM; Sadoff JC; Bodmer MW; Palardy JE; Victor GH
    J Infect Dis; 1990 Jun; 161(6):1148-52. PubMed ID: 2140582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    Shyu WC; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
    Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
    J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
    [No Abstract]   [Full Text] [Related]  

  • 14. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
    Gordin FM; Hackbarth CJ; Scott KG; Sande MA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):452-4. PubMed ID: 3159336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
    Trautmann M; Brückner O; Marre R; Hahn H
    Infection; 1988; 16(1):49-53. PubMed ID: 3283038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR; Derman DP; Perkins S; Cassel R
    J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activity of apalcillin and gentamicin in a combination therapy in experimental Pseudomonas bacteraemia of neutropenic mice.
    Fu KP; Hetzel N; Hung PP; Gregory FJ
    J Antimicrob Chemother; 1986 Apr; 17(4):499-503. PubMed ID: 3710958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients.
    Bodey GP; Valdivieso M; Feld R; Rodriguez V; McCredie K
    Am J Med Sci; 1977; 273(3):309-18. PubMed ID: 326048
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice.
    Zhi JG; Nightingale CH; Quintiliani R
    J Pharm Sci; 1988 Nov; 77(11):991-2. PubMed ID: 3225762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.